Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Clinical trial NCT01178346 · COMPLETED

Trial details

NCT number: NCT01178346
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2010-07-01
Primary completion: 2011-11-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.